Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KYMR | AZN | AMGN | GILD | BMY |
| Company | Kymera Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 101.75 | 157.95 | 380.76 | 131.15 | 64.89 |
| High | 104.95 | 158.56 | 390.92 | 135.57 | 66.31 |
| Low | 100.53 | 155.32 | 376.02 | 129.54 | 63.87 |
| Last | 104.39 | 155.62 | 390.02 | 135.25 | 65.89 |
| Change | +4.08 | -2.35 | +11.15 | +4.10 | +0.42 |
| Percent Change | +4.07% | -1.49% | +2.94% | +3.13% | +0.64% |
| Volume | 601,415 | 8,052,521 | 3,463,454 | 9,912,656 | 22,239,829 |
| 20-Day Average Volume | 572,133 | 3,864,081 | 2,379,925 | 6,254,927 | 12,485,775 |
| Previous | 100.31 | 157.97 | 378.87 | 131.15 | 65.47 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 110.55 | 169.55 | 372.47 | 132.11 | 61.27 |
| 20-Day Raw Stochastic | 22.41% | 5.74% | 81.63% | 47.50% | 79.59% |
| 20-Day Relative Strength | 50.29 | 34.40 | 63.25 | 53.93 | 67.54 |
| Weighted Alpha | +112.32 | -6.95 | +36.08 | +10.61 | +45.27 |
| Today's Opinion | 80% Buy | 100% Sell | 100% Buy | 24% Buy | 96% Buy |
| Yesterday's Opinion | 80% Buy | 88% Sell | 100% Buy | 24% Sell | 88% Buy |
| Last Month's Opinion | 100% Buy | 8% Buy | 72% Buy | 56% Sell | 16% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.80% since 07/28/26 | -9.79% since 07/28/26 | -0.81% since 07/28/26 | -0.40% since 07/28/26 | +3.44% since 07/28/26 |
| Low | 99.52 on 08/03/26 | 153.41 on 08/03/26 | 375.96 on 08/03/26 | 128.28 on 07/30/26 | 62.23 on 07/30/26 |
| High | 108.28 on 07/29/26 | 175.04 on 07/29/26 | 397.88 on 07/29/26 | 134.64 on 07/29/26 | 68.10 on 08/03/26 |
| 1-Month | |||||
| %Chg | -8.16% since 07/02/26 | -20.27% since 07/02/26 | +4.21% since 07/02/26 | +1.92% since 07/02/26 | +13.18% since 07/02/26 |
| Low | 99.52 on 08/03/26 | 153.41 on 08/03/26 | 353.95 on 07/15/26 | 127.61 on 07/23/26 | 56.49 on 07/06/26 |
| High | 120.90 on 07/07/26 | 193.79 on 07/07/26 | 398.00 on 07/28/26 | 140.61 on 07/17/26 | 68.10 on 08/03/26 |
| 3-Month | |||||
| %Chg | +24.71% since 05/04/26 | -15.19% since 05/04/26 | +20.40% since 05/04/26 | +0.83% since 05/04/26 | +14.66% since 05/04/26 |
| Low | 69.48 on 06/03/26 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 130.05 on 06/25/26 | 196.41 on 07/02/26 | 398.00 on 07/28/26 | 140.61 on 07/17/26 | 68.10 on 08/03/26 |
| 6-Month | |||||
| %Chg | +34.16% since 02/04/26 | -16.99% since 02/04/26 | +6.47% since 02/04/26 | -8.51% since 02/04/26 | +14.18% since 02/04/26 |
| Low | 69.48 on 06/03/26 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 130.05 on 06/25/26 | 212.71 on 02/18/26 | 398.00 on 07/28/26 | 157.29 on 02/11/26 | 68.10 on 08/03/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,251,300 | 244,996,944 | 204,479,184 | 162,831,888 | 133,736,552 |
| Shares Outstanding, K | 82,258 | 1,550,908 | 539,708 | 1,241,570 | 2,042,715 |
| Annual Sales, $M | 39,210,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income, $M | -311,350,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Qtr Sales, $M | 34,370,000 | 15,384,000,000 | 8,618,000,000 | 6,960,000,000 | 12,973,000,000 |
| Last Qtr Income, $M | -69,230,000 | 2,507,000,000 | 1,819,000,000 | 2,021,000,000 | 3,317,000,000 |
| 60-Month Beta | 1.95 | 0.26 | 0.41 | 0.32 | 0.22 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.71 on 04/30/26 | 2.63 on 07/27/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 2.04 on 07/30/26 |
| Latest Earnings Date | 08/05/26 | 11/05/26 | 08/04/26 | 08/04/26 | 10/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividend Date | N/A | 02/20/26 | 08/21/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.47 | 17.43 | 15.56 | 10.03 |